Pharmacokinetic and Pharmacodynamic Characterisation of an Anti-Mouse TNF Receptor 1 Domain Antibody Formatted for In Vivo Half-Life Extension.

Tumour Necrosis Factor-α (TNF-α) inhibition has been transformational in the treatment of patients with inflammatory disease, e.g. rheumatoid arthritis. Intriguingly, TNF-α signals through two receptors, TNFR1 and TNFR2, which have been associated with detrimental inflammatory and beneficial immune-...

Полное описание

Библиографические подробности

Главные авторы:	Laura J Goodall, Milan Ovecka, Daniel Rycroft, Sarah L Friel, Andrew Sanderson, Prafull Mistry, Marie L Davies, A Allart Stoop
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Public Library of Science (PLoS) 2015-01-01
Серии:	PLoS ONE
Online-ссылка:	http://europepmc.org/articles/PMC4564187?pdf=render
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!